..read more

A pioneering #ultrasound treatment could help treat hypothalamic hamartomas, a rare, benign mass in the #brain that can cause #epilepsy symptoms and unintentional giggling #seizures. https://twitter.com/epilepsy2018 https://www.linkedin.com/in/jessica-siler-244539133/ Source Josh Barney – University of Virginia ..read more

 Join us @ Tokyo, Japan from November 16-17,2018 https://www.linkedin.com/feed/update/urn:li:activity:6407805650302230528 https://twitter.com/epilepsy2018 ..read more

About Conference Conference Series llc Ltd provides the perfect platform for global networking and our Epilepsy Treatment 2019 conference aims to gather the Professors, Researchers, Business Delegates, and Scientists, students across the globe to provide an international forum for the dissemination of original research results, new ideas and practical development experiences. We are truly delighted to invite you to attend the 5th  World Congress on Epilepsy and Treatment, during August 19-20, 2019 at Tokyo, Japan. Epilepsy treatment 2019 will provide two days of robust discussions for the tre ..read more

https://epilepsy.neurologyconference.com ..read more

Abstract  @Cheryl Shoubridge, PhD, University of Adelaide to 4th World Congress on Epilepsy and Treatment  on November 16-17,2018 at Tokyo, Japan.Iqsec2 knockout mice recapitulate the intellectual disability and epilepsy phenotype of patients with loss-of-function mutations. Cheryl Shoubridge is an Associate Professor of Human Genetics with a research focus on investigating the molecular pathogenesis underpinning genetic causes of intellectual disability and seizures. Her research utilizes numerous experimental models relevant to the associated clinical phenotypes, including rodent models, pr ..read more

Here is the Tentative agenda of Epilepsy Treatment Conference 2018,Tokyo Japan from November 16-17,2018. https://epilepsy.neurologyconference.com ..read more

DEA reschedules Epidiolex, marijuana-derived drug, paving the way for it to hit the marketThe Drug Enforcement Administration has rescheduled Epidiolex, paving the way for GW Pharmaceuticals to start selling the first FDA-approved drug derived from cannabis, but stopped short of reclassifying all cannabidiol products. The Food and Drug Administration in June approved Epidiolex, which is derived from cannabidiol, or CBD, a molecule contained in the marijuana plant. This forced the DEA to consider how it would classify Epidiolex since marijuana is considered a schedule 1 drug, which it defines a ..read more

Let us celebrate the month of Epilepsy at Singapore on September 19-20,2018 @Epilepsy and Nervous system Disorders Congress https://epilepsy.neurologyconference.com/abstract-submission.php ..read more

On the Occasion of World Pharmacists Day  Avail $100 off at 4th World congress on Epilepsy and Treatment 2018 Tokyo Japan,November 16-17,2018. https://epilepsy.neurologyconference.com/registration.php ..read more